Does [99mTc]-3,3-diphosphono-1,2-propanodicarboxylic acid (DPD) soft tissue uptake allow the identification of patients with the diagnosis of cardiac transthyretin-related (ATTR) amyloidosis with higher risk for polyneuropathy?

BACKGROUND: With the introduction of several drugs for the therapy of transthyretin-related amyloidosis (ATTR) which slow down the disease, early detection of polyneuropathy (PNP) is becoming increasingly of interest. [99mTc]-3,3-Diphosphono-1,2-Propanodicarboxylic Acid (DPD) bone scintigraphy, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Wollenweber, Tim, Kretschmer-Chott, Elisabeth, Wurm, Raphael, Rasul, Sazan, Kulterer, Oana, Rettl, Rene, Duca, Franz, Bonderman, Diana, Sühs, Kurt-Wolfram, Hacker, Marcus, Traub-Weidinger, Tatjana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984356/
https://www.ncbi.nlm.nih.gov/pubmed/35817943
http://dx.doi.org/10.1007/s12350-022-02986-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984356/
https://www.ncbi.nlm.nih.gov/pubmed/35817943
http://dx.doi.org/10.1007/s12350-022-02986-7

Ejemplares similares